Retail sale of other food
MYCOTECH PHARMA AS
Revenue 2024
NOK 3.5m
Operating profit
NOK −29.6m
Equity
NOK 20.2m
Incorporated
2022
Share capital
NOK 11.3m
Key figures · 2024
Current ratio
4.03
Equity ratio
36.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -838.3% | |
| Net margin (%%) | -704.1% | |
| Return on assets (%%) | -53.6% | |
| Likviditet | ||
| Current ratio | 4.03 | |
| Working capital | 24.4m | |
| Soliditet | ||
| Equity ratio (%%) | 36.5% | |
| Debt-to-equity ratio | 1.74 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.